Pharmaceutical Incentives: Some physicians receive payments from drug companies—think consulting fees, speaking gigs, or "educational" grants. These aren’t tied to specific prescriptions legally, but the cozy relationship can nudge doctors toward favoring certain drugs. A 2016 ProPublica analysis found docs who got money from pharma were more likely to prescribe brand-name meds over generics.
In-Office Dispensing: In some states, physicians can sell medications directly to patients through their practice. They buy drugs wholesale, mark them up, and pocket the difference. It’s legal, convenient for patients, and profitable—sometimes 50-100% margins—but it raises questions about whether they’re prescribing what’s best or what’s lucrative.
Fee-for-Service Model: Under this common setup, more patient visits mean more revenue. Prescribing meds can keep patients coming back for follow-ups, refills, or managing side effects, indirectly boosting income. It’s not profit from the drug itself, but from the revolving door it creates.
Specialty Clinics: Think weight loss, pain management, or anti-aging practices. Some docs push compounded drugs or off-label prescriptions (like certain peptides or hormones) that patients buy through affiliated pharmacies—where the doc might have a financial stake.
Home
Today's Posts
Members
Chat
Contact
Login
Register